MBNL1 Inhibitors

Muscleblind-like 1 (MBNL1) is a protein that plays a critical role in the regulation of alternative splicing, a fundamental process in gene expression that allows a single gene to produce multiple protein variants. MBNL1 is a member of the Muscleblind-like (MBNL) protein family, which includes MBNL2 and MBNL3. These proteins are primarily known for their involvement in regulating alternative splicing events in muscle and other tissues. MBNL1 is particularly abundant in skeletal muscle and is essential for the proper development and functioning of muscle cells. The main function of MBNL1 is to bind to specific RNA sequences, known as RNA motifs, in pre-mRNA molecules. By binding to these motifs, MBNL1 influences the splicing process, ensuring that the correct exons (coding regions) are included or excluded in the final mRNA transcript. This regulation is crucial for the proper production of muscle-specific proteins and the maintenance of muscle function. MBNL1 also plays a role in other tissues and cell types, contributing to the regulation of alternative splicing in a broader context. Inhibition of MBNL1 is a topic of interest in research related to myotonic dystrophy, a genetic disorder characterized by muscle weakness and myotonia (prolonged muscle contractions). In myotonic dystrophy, the function of MBNL1 is disrupted due to sequestration by expanded RNA repeats. This sequestration blocks MBNL1 from performing its normal role in alternative splicing regulation, leading to abnormal splicing patterns and the production of toxic RNA species.